175 related articles for article (PubMed ID: 31844885)
21. Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe.
Mduluza T; Jones C; Osakunor DNM; Lim R; Kuebel JK; Phiri I; Manangazira P; Tagwireyi P; Mutapi F
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008388. PubMed ID: 32569278
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic and operational profiles of metrifonate and praziquantel in Schistosoma haematobium infection.
Feldmeier H; Chitsulo L
Arzneimittelforschung; 1999 Jul; 49(7):557-65. PubMed ID: 10442201
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.
Mutapi F; Ndhlovu PD; Hagan P; Spicer JT; Mduluza T; Turner CM; Chandiwana SK; Woolhouse ME
J Infect Dis; 1998 Jul; 178(1):289-93. PubMed ID: 9652458
[TBL] [Abstract][Full Text] [Related]
24. Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.
Rujeni N; Nausch N; Midzi N; Mduluza T; Taylor DW; Mutapi F
Parasite Immunol; 2012 Jun; 34(6):330-40. PubMed ID: 22429049
[TBL] [Abstract][Full Text] [Related]
25. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
[TBL] [Abstract][Full Text] [Related]
26. The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium.
Mutapi F; Mduluza T; Ndhlovu PD
Mem Inst Oswaldo Cruz; 2002; 97 Suppl 1():173-80. PubMed ID: 12426616
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire.
N'Goran EK; Gnaka HN; Tanner M; Utzinger J
Ann Trop Med Parasitol; 2003 Jan; 97(1):37-51. PubMed ID: 12662421
[TBL] [Abstract][Full Text] [Related]
28. Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection.
Grogan JL; Kremsner PG; Deelder AM; Yazdanbakhsh M
J Infect Dis; 1998 May; 177(5):1433-7. PubMed ID: 9593042
[TBL] [Abstract][Full Text] [Related]
29. Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.
Labuda LA; Ateba-Ngoa U; Feugap EN; Heeringa JJ; van der Vlugt LE; Pires RB; Mewono L; Kremsner PG; van Zelm MC; Adegnika AA; Yazdanbakhsh M; Smits HH
PLoS Negl Trop Dis; 2013; 7(3):e2094. PubMed ID: 23505586
[TBL] [Abstract][Full Text] [Related]
30. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.
Touré S; Zhang Y; Bosqué-Oliva E; Ky C; Ouedraogo A; Koukounari A; Gabrielli AF; Bertrand S; Webster JP; Fenwick A
Bull World Health Organ; 2008 Oct; 86(10):780-7, A. PubMed ID: 18949215
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
32. Schistosoma haematobium and soil-transmitted Helminths in Tana Delta District of Kenya: infection and morbidity patterns in primary schoolchildren from two isolated villages.
Njaanake KH; Vennervald BJ; Simonsen PE; Madsen H; Mukoko DA; Kimani G; Jaoko WG; Estambale BB
BMC Infect Dis; 2016 Feb; 16():57. PubMed ID: 26842961
[TBL] [Abstract][Full Text] [Related]
33. Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen.
Darko SN; Hanson H; Twumasi-Ankrah S; Baffour-Awuah S; Adjei-Kusi P; Yar D; Owusu-Dabo E
BMC Infect Dis; 2020 May; 20(1):323. PubMed ID: 32375658
[TBL] [Abstract][Full Text] [Related]
34. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
[TBL] [Abstract][Full Text] [Related]
35. Effect of praziquantel on the immature stages of Schistosoma haematobium.
Botros S; Pica-Mattoccia L; William S; El-Lakkani N; Cioli D
Int J Parasitol; 2005 Nov; 35(13):1453-7. PubMed ID: 16002073
[TBL] [Abstract][Full Text] [Related]
36. Schistosoma haematobium (Egyptian strain): rate of development and effect of praziquantel treatment.
Botros SS; Hammam OA; El-Lakkany NM; El-Din SH; Ebeid FA
J Parasitol; 2008 Apr; 94(2):386-94. PubMed ID: 18564739
[TBL] [Abstract][Full Text] [Related]
37. [Dynamics of Egg Excretion of
Niaré DS; Doumtabe D; Ongoiba A; Sidibé K; Traoré A; Sangala J; Kayentao K; Tran TM; Crompton PD; Traoré B; Doumbo OK
Bull Soc Pathol Exot; 2018; 111(2):114-120. PubMed ID: 30789237
[TBL] [Abstract][Full Text] [Related]
38. Immune response in chronic Schistosomiasis haematobium and mansoni. Reversibility of alterations after anti-parasitic treatment with praziquantel.
Feldmeier H; Gastl GA; Poggensee U; Daffalla AA; Nogueira-Queiroz JA; Capron A; Peter HH
Scand J Immunol; 1988 Aug; 28(2):147-55. PubMed ID: 3137653
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and treatment of an imported case of schistosomiasis haematobium].
Yan-Rong L; Han-Guo X; Zhu-Yun C; Li-Zhen X; Rong-Yan Z
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 Jan; 29(1):108-110. PubMed ID: 29469403
[TBL] [Abstract][Full Text] [Related]
40. Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium.
Mutapi F; Roussilhon C; Mduluza T; Druilhe P
Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):405-9. PubMed ID: 17568947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
